Buy U-47700 powder/ CAS 82657-23-6 / online

U-47700 (also known as “Pink”) is a synthetic opioid analgesic first developed in the 1970s by Upjohn Laboratories during efforts to identify non-morphine-based painkillers. Though originally studied as a potential analgesic, it was never approved for medical use. Decades later, it appeared on the unregulated market as a designer drug, leading to severe health and legal consequences. Buy U-47700 powder/ CAS 82657-23-6 / online

Today, U-47700 is studied only in forensic toxicology, analytical chemistry, and public health research contexts.

2. Informational: Chemical and Pharmacological Profile

3. Mechanism of Action

U-47700 acts as a μ-opioid receptor agonist, mimicking the effects of morphine but with significantly higher potency. It reduces pain perception by modulating neuronal activity in the central nervous system, but this same property also causes dangerous respiratory suppression and dependence.

Because of its potency and narrow therapeutic index, U-47700 has been linked to numerous overdose fatalities, leading to its international scheduling as a controlled substance.

4. Scientific and Forensic Applications

Even though human use is illegal, U-47700 retains relevance in:

• Forensic toxicology – Identification and quantification in biological samples during post-mortem investigations.
• Analytical chemistry – Development of detection methods using GC-MS, LC-MS/MS, and IR spectroscopy.
• Public health monitoring – Tracking trends in synthetic opioid distribution and overdose incidents.
• Pharmaceutical research (historical) – Comparative studies of opioid receptor activity among synthetic analogues.

5. Health and Safety Risks

• Respiratory depression: The most common cause of death from overdose.
• Rapid tolerance and dependence: Even minimal repeated exposure leads to addiction.
• Central nervous system depression: Can result in coma or cardiac arrest.
• Unknown impurities: Illicit production often involves toxic by-products.

Because of these risks, no medical or personal use is authorized, and handling should be restricted to licensed research facilities only.

6. Legal Framework and International Control

Researchers wishing to study U-47700 must apply for special controlled substance licenses and follow DEA/EMA-approved handling and disposal protocols. Buy U-47700 powder/ CAS 82657-23-6 / online

7. Navigational: Detection and Analysis

In research and law enforcement, U-47700 detection involves sophisticated instrumentation:

• LC-MS/MS for plasma and urine quantification.
• GC-MS for structural identification.
• FT-IR and NMR for reference standard verification.
• Immunoassay development for rapid screening in clinical settings.

Such methods are critical for forensic laboratories monitoring emerging synthetic opioids.

8. Ethical and Legal Considerations for Researchers

• Obtain institutional approval (IRB or ethics board).
• Work within a licensed facility that can store and dispose of controlled substances.
• Maintain chain-of-custody documentation for all samples.
• Never distribute, sell, or use outside a legal research framework.

Violation of controlled substance laws can result in severe criminal penalties and loss of institutional funding.

9. Conclusion U-47700 NEAR

U-47700 remains an important case study in synthetic opioid pharmacology and public health risk management. While it was once seen as a potential analgesic, it now serves primarily as a forensic and analytical reference for scientists studying opioid analogues, addiction, and regulatory control systems.

Safe, legal study of U-47700 requires:

• Institutional licensing for controlled substances.
• Collaboration with certified forensic laboratories.
• Full compliance with DEA, EMA, or equivalent national regulations.

By maintaining strict ethical and safety standards, researchers can help advance the understanding of synthetic opioid mechanisms and public safety prevention strategies. Buy U-47700 powder/ CAS 82657-23-6 / online

🔍 U-47700 Keywords

U-47700 research compound • U-47700 opioid • forensic toxicology opioid • synthetic opioid regulation • U-47700 legal status • opioid receptor agonist • DEA Schedule I opioids • controlled substance research

Historical and Research Context

U-47700 serves as a precursor compound for selective kappa-opioid receptor ligands, including U-50488, U-51754 (which differs by a single methylene spacer), and U-69,593. These compounds share similar structural characteristics and are utilized primarily in research settings. Although U-47700 itself is not used in clinical practice, its related compounds play a role in scientific studies.

Regulatory and Safety Information

U-47700 is a highly potent substance that has been implicated in several opioid overdoses and fatalities. Notably, it was detected in conjunction with fentanyl in the toxicological analysis of the American musician Prince in 2016. Due to its high potency and risk of abuse, U-47700 is classified as a Schedule I controlled substance in the United States. This designation indicates that it is illegal to manufacture, distribute, or possess the substance.

Certified Spiking Solution®

For laboratory and forensic purposes, a Certified Spiking Solution® of U-47700 is available. This solution is intended for use in urine drug testing, clinical toxicology, or forensic analysis applications, utilizing techniques such as LC-MS/MS or GC-MS. Cerilliant’s product is part of the Centers for Disease Control and Prevention (CDC) Opioid CRM Kit, which includes over 40 certified reference materials (CRMs) to aid in the response to the opioid crisis. These kits are provided free of charge to eligible drug testing laboratories in the United States. Laboratories must have current DEA registration and comply with state and local regulations to request a kit. Detailed instructions for obtaining a free Opioid CRM Kit can be found on the Cerilliant website.

Physical and Chemical Properties

• Appearance: Yellow crystalline solid
• LogP: 1.21
• Molecular Formula: C22H28O4
• Molecular Weight: 356.46
• Exact Mass: 356.198761
• EINECS Number: 2017-001-1
• Hydrogen Bond Acceptors: 4
• Hydrogen Bond Donors: 1
• Boiling Point: Estimated around 584.7 ± 50.0 °C
• Flash Point: 207.3 ± 23.6 °C

Side Effects and Risks

While U-47700 has not been studied in human trials, it is anticipated to produce effects similar to other potent opioid agonists, including substantial analgesia, sedation, euphoria, constipation, itching, and potentially life-threatening respiratory depression. Tachycardia has also been reported. Users may develop tolerance and dependence over time.

Fatalities Associated with U-47700

U-47700 has been linked to several fatalities worldwide. Combined use with fentanyl and flubromazepam has resulted in deaths in Belgium and Germany. In the United States, as of December 2017, at least 46 fatalities were associated with U-47700. The compound was notably found in the toxicology report of Prince, highlighting its dangerous potential.

Detection in Biological Fluids

U-47700 can be detected in biological fluids such as serum, plasma, blood, or urine. This detection is crucial for monitoring abuse, diagnosing poisoning, or assisting in medicolegal investigations. Typical serum or blood concentrations in intoxicated individuals range from 10–250 μg/L, while concentrations in deceased victims of acute overdose range from 100–1,500 μg/L. Detection is usually performed using liquid chromatography-mass spectrometry (LC-MS).

Purchase and Order Information

To purchase U-47700 powder, please ensure you are compliant with local regulations and possess any required licenses or registrations. For further details on ordering and availability, visit the appropriate supplier’s website or contact them directly.